213 related articles for article (PubMed ID: 38796701)
1. Decoding the specificity of m
Cun Y; Guo W; Ma B; Okuno Y; Wang J
Mol Ther; 2024 May; ():. PubMed ID: 38796701
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNA-Mediated N6-Methyladenosine (m
Hashemi M; Daneii P; Zandieh MA; Raesi R; Zahmatkesh N; Bayat M; Abuelrub A; Khazaei Koohpar Z; Aref AR; Zarrabi A; Rashidi M; Salimimoghadam S; Entezari M; Taheriazam A; Khorrami R
Noncoding RNA Res; 2024 Mar; 9(1):84-104. PubMed ID: 38075202
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
[TBL] [Abstract][Full Text] [Related]
4. Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.
Qu X; Zhang Y; Sang X; Ren D; Zhao H; Wong STC
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804965
[TBL] [Abstract][Full Text] [Related]
5. Roles of N
Wang X; Xie H; Ying Y; Chen D; Li J
J Cell Mol Med; 2020 Sep; 24(18):10302-10310. PubMed ID: 32808488
[TBL] [Abstract][Full Text] [Related]
6. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated N6-methyladenosine (m
Wang YF; Ge CM; Yin HZ; Dai ZH; Dong JP; Ji M; Yang F
Ann Hepatol; 2021; 25():100538. PubMed ID: 34555511
[TBL] [Abstract][Full Text] [Related]
8. The emerging roles of N6-methyladenosine RNA methylation in human cancers.
Shen H; Lan Y; Zhao Y; Shi Y; Jin J; Xie W
Biomark Res; 2020; 8():24. PubMed ID: 32612834
[TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
10. Effects of N
Zhu YF; Wang SJ; Zhou J; Sun YH; Chen YM; Ma J; Huo XX; Song H
Front Oncol; 2022; 12():897895. PubMed ID: 35707365
[TBL] [Abstract][Full Text] [Related]
11. Biological roles of RNA m
Song H; Zhang J; Liu B; Xu J; Cai B; Yang H; Straube J; Yu X; Ma T
Biomark Res; 2022 Apr; 10(1):15. PubMed ID: 35365216
[TBL] [Abstract][Full Text] [Related]
12. The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer.
Wu W; Zhang F; Zhao J; He P; Li Y
Exp Cell Res; 2022 Jun; 415(2):113115. PubMed ID: 35341774
[TBL] [Abstract][Full Text] [Related]
13. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine Modifications in the Female Reproductive System: Roles in Gonad Development and Diseases.
Mu H; Li H; Liu Y; Wang X; Mei Q; Xiang W
Int J Biol Sci; 2022; 18(2):771-782. PubMed ID: 35002524
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression.
Liu R; Jia Y; Kong G; He A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107
[TBL] [Abstract][Full Text] [Related]
16. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers.
Shi H; Wei J; He C
Mol Cell; 2019 May; 74(4):640-650. PubMed ID: 31100245
[TBL] [Abstract][Full Text] [Related]
17. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-Methyladenosine Modifications and Its Roles in Alzheimer's Disease.
Zhang R; Zhang Y; Guo F; Li S; Cui H
Front Cell Neurosci; 2022; 16():820378. PubMed ID: 35401117
[TBL] [Abstract][Full Text] [Related]
20. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.
Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
